Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
- PMID: 1551497
- DOI: 10.2337/diab.41.3.368
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
Abstract
Insulin secretion rates can be accurately estimated from plasma C-peptide levels with a two-compartment model for C-peptide distribution and degradation. In previous studies, the kinetic parameters of C-peptide clearance were derived in each subject from the decay curve observed after bolus intravenous injection of biosynthetic human C-peptide. To determine whether standard parameters for C-peptide clearance could be defined and used to calculate insulin secretion without obtaining a decay curve in each subject, we analyzed 200 decay curves of biosynthetic human C-peptide obtained in normal, obese, and non-insulin-dependent diabetes mellitus subjects studied in our laboratory. This analysis showed that the volume of distribution and kinetic parameters of C-peptide distribution and metabolism vary by less than 30% in a population highly heterogeneous in terms of age, sex, degree of obesity, and degree of glucose tolerance. The volume of distribution correlated with the degree of obesity as quantified by body surface area (BSA). This dependence of C-peptide distribution volume on BSA was more marked in men than in women. The long half-life was slightly longer in elderly subjects than in younger adults. When effects of BSA, sex, and age were taken into account, the parameters of C-peptide kinetics were very similar in normal, obese, and diabetic subjects. Based on these findings, a simple procedure to derive standard parameters for C-peptide clearance taking into account degree of obesity, sex, and age was defined. These standard parameters resulted in estimations of mean insulin secretion rates, which differed in each subject by only 10-12% from those obtained with individual parameters. The approach of using standard rather than individual parameters did not systematically underestimate or overestimate insulin secretion so that group values for the fasting secretion rate, the mean 24-h secretion rate, and the number and the amplitude of secretory pulses obtained with standard parameters differed by only 1-2% from the values obtained with individual parameters. Furthermore, the accuracy of measurements based on standard parameters was not different from that associated with replicate determinations of the parameters of C-peptide clearance in the same subject. We conclude that it is possible to estimate insulin secretion rates from plasma C-peptide levels with standard parameters for C-peptide clearance rather than individually derived parameters without significant loss of accuracy.
Similar articles
-
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.J Clin Invest. 1986 Jan;77(1):98-105. doi: 10.1172/JCI112308. J Clin Invest. 1986. PMID: 3511094 Free PMC article.
-
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.Diabetologia. 2001 Oct;44(10):1339-48. doi: 10.1007/s001250100639. Diabetologia. 2001. PMID: 11692185
-
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.J Clin Endocrinol Metab. 1990 Jun;70(6):1594-602. doi: 10.1210/jcem-70-6-1594. J Clin Endocrinol Metab. 1990. PMID: 2189885
-
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.Diabetes. 1984 May;33(5):486-94. doi: 10.2337/diab.33.5.486. Diabetes. 1984. PMID: 6373457 Review.
-
Current approaches to measurement of insulin secretion.Diabetes Metab Rev. 1986;2(3-4):315-29. doi: 10.1002/dmr.5610020306. Diabetes Metab Rev. 1986. PMID: 3527618 Review.
Cited by
-
Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials.J Diabetes Sci Technol. 2022 Sep;16(5):1270-1298. doi: 10.1177/19322968211015268. Epub 2021 May 25. J Diabetes Sci Technol. 2022. PMID: 34032128 Free PMC article.
-
Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.Diabetes. 2023 Feb 1;72(2):299-308. doi: 10.2337/db22-0708. Diabetes. 2023. PMID: 36342518 Free PMC article. Clinical Trial.
-
Quantification of β-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeys.Diabetol Metab Syndr. 2013 Jul 25;5(1):40. doi: 10.1186/1758-5996-5-40. Diabetol Metab Syndr. 2013. PMID: 23886319 Free PMC article.
-
Blood Glucose Levels of Subelite Athletes During 6 Days of Free Living.J Diabetes Sci Technol. 2016 Nov 1;10(6):1335-1343. doi: 10.1177/1932296816648344. Print 2016 Nov. J Diabetes Sci Technol. 2016. PMID: 27301981 Free PMC article. Clinical Trial.
-
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women.Diabetologia. 2012 Dec;55(12):3228-37. doi: 10.1007/s00125-012-2701-3. Epub 2012 Aug 31. Diabetologia. 2012. PMID: 22935962
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical